| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/23/2002 | US6376498 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 04/23/2002 | US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 04/23/2002 | US6376493 Selective inhibition of phosphodiesterase iv and tumor necrosis factor; useful in treating osteoporosis, tumors, autoimmune diseases, rheumatic diseases, and asthma |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376472 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 04/23/2002 | US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders |
| 04/23/2002 | US6376242 Reduce the number of circulating platelets to low or below normal levels. |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6375972 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/23/2002 | CA2004127C Novel aminobenzoates |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030937A2 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | WO2002030914A1 Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them |
| 04/18/2002 | WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 04/18/2002 | WO2002030910A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis |
| 04/18/2002 | WO2002030900A1 Non-deliquescent salt of 4-hydroxypiperidine derivative |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 04/18/2002 | WO2002030874A2 Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030873A1 Mmp inhibitor |
| 04/18/2002 | WO2002030868A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030485A1 Embolic materials |
| 04/18/2002 | WO2002030453A1 Methods of inhibiting angiogenesis using nadph oxidase inhibitors |
| 04/18/2002 | WO2002030450A1 Use of d-leu deltorphin for protection against ischemia and reperfusion injury |
| 04/18/2002 | WO2002030431A1 Obesity regulatory compositions |
| 04/18/2002 | WO2002030428A1 Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2002 | WO2002030423A1 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030414A1 Compositions comprising modafinil compounds |
| 04/18/2002 | WO2002030413A1 Pharmaceutical solutions of modafinil compounds |
| 04/18/2002 | WO2002030407A1 ESTROGEN RECEPTOR-β LIGANDS |
| 04/18/2002 | WO2002030353A2 NF-λB INHIBITORS |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002009682A3 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2002002541A3 Inhibitors of copper-containing amine oxidases |
| 04/18/2002 | WO2001093806A3 HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001070209A3 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001068070A3 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001060400A3 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001058483A3 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 04/18/2002 | WO2001056353A3 Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045761 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 04/18/2002 | US20020045751 Thyromimetic organic compounds |
| 04/18/2002 | US20020045656 NMDA receptor NR2B subunit antagonist and a neutrophil inhibiting factor; therapies that reduce or prevent neuronal dysfunction and death after ischemic, hypoxic or traumatic CNS insult |
| 04/18/2002 | US20020045651 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones |
| 04/18/2002 | US20020045648 Therapeutic compositions comprising excess enantiomer |
| 04/18/2002 | US20020045645 Lactone integrin antagonists |
| 04/18/2002 | US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors |
| 04/18/2002 | US20020045637 Novel 20,21-dinor-eburnamenine |
| 04/18/2002 | US20020045636 Administering a drug composition comprising an opioidergic agent (e.g. an opiate antagonist, an opiate having mu-agonist activity, or a combination) and an insulin secretagogue |
| 04/18/2002 | US20020045635 Novel mGluR antagonists and a method for their synthesis |
| 04/18/2002 | US20020045633 Use of moxonidine for postmyocardial infarction treatment |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 04/18/2002 | US20020045616 Lactam inhibitors of FXa and method |
| 04/18/2002 | US20020045613 1-aroyl-piperidinyl benzamidines |
| 04/18/2002 | US20020045595 N6 heterocyclic 8-modified adenosine derivatives |
| 04/18/2002 | US20020045593 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons |
| 04/18/2002 | US20020045586 Mono-and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | US20020045573 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045566 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |